| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |